Clinical predictors of remission and persistence of adult-onset asthma
- PMID: 28438546
- DOI: 10.1016/j.jaci.2017.03.034
Clinical predictors of remission and persistence of adult-onset asthma
Abstract
Background: Adult-onset asthma is an important but relatively understudied asthma phenotype and little is known about its natural course and prognosis. The remission rate is believed to be low, and it is still obscure which factors predict remission or persistence of the disease.
Objective: This study sought to determine the remission rate and identify predictors of persistence and remission of adult-onset asthma.
Methods: Two hundred adult patients with recently diagnosed (<1 year) asthma were recruited from secondary and tertiary pulmonary clinics and prospectively followed for 5 years. Clinical, functional, and inflammatory parameters were assessed at baseline and at yearly visits. Asthma remission was defined as absence of asthma symptoms for ≥1 year and no asthma medication use for ≥1 year. Descriptive statistics and logistic regression analysis were performed.
Results: Five-year follow-up data of 170 patients (85%) was available. Of these, 27 patients (15.9%) experienced asthma remission. Patients with asthma persistence were older, had worse asthma control, required higher doses of inhaled corticosteroids, had more severe airway hyperresponsiveness, more often nasal polyps, and higher levels of blood neutrophils as compared to patients who experienced clinical remission. In a multivariable logistic regression analysis, only moderate to severe bronchial hyperresponsiveness and nasal polyps were independent predictors of asthma persistence. Patients with these 2 characteristics had <1% chance of asthma remission.
Conclusions: One in 6 patients with adult-onset asthma experiences remission within the first 5 years of the disease. In patients with moderate to severe bronchial hyperresponsiveness and nasal polyposis, the chance of remission is close to zero.
Keywords: Adult-onset; asthma; clinical predictors; persistence; prognosis; prospective study; remission.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Comment in
-
Comments on clinical predictors of remission and persistence of adult-onset asthma.J Allergy Clin Immunol. 2018 Jan;141(1):458-459. doi: 10.1016/j.jaci.2017.08.010. Epub 2017 Sep 28. J Allergy Clin Immunol. 2018. PMID: 28967479 No abstract available.
-
Reply.J Allergy Clin Immunol. 2018 Jan;141(1):459. doi: 10.1016/j.jaci.2017.07.037. Epub 2017 Sep 28. J Allergy Clin Immunol. 2018. PMID: 28967480 No abstract available.
-
Identification of remission in adult-onset asthma.Lancet Respir Med. 2018 Jun;6(6):417-418. doi: 10.1016/S2213-2600(18)30175-9. Epub 2018 Apr 23. Lancet Respir Med. 2018. PMID: 29699818 No abstract available.
Similar articles
-
Severe adult-onset asthma: A distinct phenotype.J Allergy Clin Immunol. 2013 Aug;132(2):336-41. doi: 10.1016/j.jaci.2013.04.052. Epub 2013 Jun 24. J Allergy Clin Immunol. 2013. PMID: 23806634
-
Clinical Phenotypes of Nasal Polyps and Comorbid Asthma Based on Cluster Analysis of Disease History.J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1297-1305.e1. doi: 10.1016/j.jaip.2017.09.020. Epub 2017 Oct 31. J Allergy Clin Immunol Pract. 2018. PMID: 29100865
-
Airway dysfunction in nasal polyposis: a spectrum of asthmatic disease?Clin Exp Allergy. 2011 Oct;41(10):1379-85. doi: 10.1111/j.1365-2222.2011.03793.x. Epub 2011 Jun 16. Clin Exp Allergy. 2011. PMID: 21676042 Clinical Trial.
-
[Allergic inflammation in the development of nonspecific bronchial hyperresponsiveness in asthma].Pol Merkur Lekarski. 2002 Jun;12(72):515-8. Pol Merkur Lekarski. 2002. PMID: 12362673 Review. Polish.
-
Predicting the course of asthma from childhood until early adulthood.Curr Opin Allergy Clin Immunol. 2022 Apr 1;22(2):115-122. doi: 10.1097/ACI.0000000000000810. Curr Opin Allergy Clin Immunol. 2022. PMID: 35197433 Free PMC article. Review.
Cited by
-
Clinical Remission of Asthma and Allergic Rhinitis - in a Longitudinal Population Study.J Asthma Allergy. 2022 Nov 4;15:1569-1578. doi: 10.2147/JAA.S378584. eCollection 2022. J Asthma Allergy. 2022. PMID: 36387839 Free PMC article.
-
Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis.Clin Transl Allergy. 2020 Jun 26;10:25. doi: 10.1186/s13601-020-00330-1. eCollection 2020. Clin Transl Allergy. 2020. PMID: 32607141 Free PMC article.
-
Natural history and associated early life factors of childhood asthma: a population registry-based cohort study in Denmark.BMJ Open. 2021 Nov 25;11(11):e045728. doi: 10.1136/bmjopen-2020-045728. BMJ Open. 2021. PMID: 34824103 Free PMC article.
-
Risk factors associated with comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: a cross-sectional study.BMC Pulm Med. 2022 Sep 7;22(1):338. doi: 10.1186/s12890-022-02138-0. BMC Pulm Med. 2022. PMID: 36071399 Free PMC article.
-
Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?BMC Pulm Med. 2023 Jul 18;23(1):266. doi: 10.1186/s12890-023-02556-8. BMC Pulm Med. 2023. PMID: 37464395 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical